References
- PalmieriFMBartonDLChallenges of oral medications in patients with advanced breast cancerSemin Oncol Nurs2007234 Suppl 21722
- LiuGFranssenEFitchMIPatient preferences for oral versus intravenous palliative chemotherapyJ Clin Oncol1997151101158996131
- TsoutsouPGBelkacemiYGligorovJOptimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to considerOncologist2010151169117821041378
- DemetriGDvon MehrenMBlankeCDEfficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumorsN Engl J Med200234747248012181401
- WeltAvon MinckwitzGOberhoffCPhase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancerAnn Oncol200516646915598940
- GeyerCEForsterJLindquistDLapatinib plus capecitabine for HER2-positive advanced breast cancerN Engl J Med20063552733274317192538
- ShepherdFARodrigues PereiraJErlotinib in previously treated non-small-cell lung cancerN Engl J Med200535312313216014882
- MotzerRJMichaelsonMDRedmanBGActivity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinomaJ Clin Oncol200624162416330672
- LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med200835937839018650514
- Centers for Disease Control and Prevention (CDC)Cancer survivors – United States, 2007MMWR Morb Mortal Wkly Rep20116026927221389929
- XueDLiPPClinical benefits as endpoints in advanced non-small cell lung cancer treated with integrative medicineChin J Integr Med20111722823121359926
- World Health OrganizationWHO handbook for reporting results of cancer treatmentNeoplasma1980203746
- AaronsonNKAhmedzaiSBergmanBThe European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst1993853653768433390
- OkenMMCreechRHTormeyDCToxicity and response criteria of the Eastern Cooperative Oncology GroupAm J Clin Oncol198256496557165009
- OliveiraEXMeloECPinheiroRSAccess to cancer care: mapping hospital admissions and high-complexity outpatient care flows. The case of breast cancerCad Saude Publica201127317326 Portuguese21359468
- HaynesRBTaylorDWSackettDLCompliance In Health CareBaltimore, MDThe Johns Hopkins University Press1979
- LoveRRCameronLConnellBLLeventhalHSymptoms associated with tamoxifen treatment in postmenopausal womenArch Intern Med1991151184218471888251
- TebbiCKTreatment compliance in childhood and adolescenceCancer199371Suppl 10344134498490895
- LeeJKGraceKATaylorAJEffect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trialJAMA20062962563257117101639
- CallejaPatriciaHuarteJuditAgüerosMaiteRuiz-GatónLuisaEspuelasSocorroIracheJuan MMolecular buckets: cyclodextrins for oral cancer therapyTherapeutic Delivery201231435722833932
- LiuGFranssenEFitchMIPatient preferences for oral versus intravenous palliative chemotherapyJ Clin Oncol1997151101158996131
- BedellCHA changing paradigm for cancer treatment: the advent of new oral chemotherapy agentsClin J Oncol Nurs20037Suppl 65914705494
- RuddyKMayerEPartridgeAPatient adherence and persistence with oral anticancer treatmentCA Cancer J Clin200959566619147869
- WeingartSNBrownEBachPBNCCN Task Force Report: oral chemotherapyJ Natl Compr Canc Netw20086Suppl 3114
- HallMLloydHEvaluating patients’ experience of home and hospital chemotherapyCancer Nurs Pract200872326
- SweeneyLHalpertAWaranoffJPatient-centered management of complex patients can reduce costs without shortening lifeAm J Manag Care200713849217286528
- TralongoPFerraùFBorsellinoNCancer patient-centered home care: a new model for health care in oncologyTher Clin Risk Manag2011738739221941445